Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations P. WiedemannH. BönischM. Brüss Pages: 443 - 453
Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice P. TutkaJ. ŁuszczkiM. Wielosz Pages: 455 - 466
The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells W. MaruyamaT. TakahashiM. Naoi Pages: 467 - 481
Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease S.-J. TsaiH.-C. LiuC.-J. Hong Pages: 483 - 488
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa E. R. BruntD. J. Brookson behalf of the 043 Study Group Pages: 489 - 501
Steele-Richardson-Olszewski-Syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI G. ArnoldJ. SchwarzW. H. Oertel Pages: 503 - 512
Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2 Y. HasegawaS. HiguchiH. Miyaoka Pages: 513 - 521
Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats J. L. WileyK. L. Kennedy Pages: 523 - 535
Alzheimer's vaccine: a cure as dangerous as the disease? G. MünchS. R. Robinson Rapid Communication Pages: 537 - 539